Scimago Lab
powered by Scopus
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


eISSN: 1643-3750

Get your full text copy in PDF

Non-neoplastic lymphocyte subsets in patients with B-cell chronic lymphocytic leukemia (B-CLL)

Urszula Podstawka, Joanna Kopeć-Szlężak, Grażyna Pałynyczko, Ewa Mendek-Czajkowska, Lech Konopka

Med Sci Monit 1999; 5(2): CR239-245

ID: 505095

Since the early 1980s we observed populations of T lymphocytes and NK cells of B-cell chronic lymphocytic leukemia (B-CLL)patients, reveal changes as compared with T and NK cells of healthy donors. The aim of this study was to determine relations between T-lymphocyte subpopulations and NK-cell subsets in patients with B-CLL in various stages of the disease.Peripheral blood cells of B-CLL patients had been analysed by means of flow cytometry and monoclonal antibodies. Lymphocyte surface markers had been evaluated by means of direct immunofluorescence. We evaluated the absolute number of each lymphocyte subset. Study results revealed that there was a significant increase in the number of T- and NK-cell populations that correlates with the progression of the disease. Following effective therapy of B-CLL Rai stage III/IV patients (blood lymphocyte count <30x109/l) there was a considerable decrease of  T CD3+ and T CD8+ lymphocytes (to control values) and a significant decrease of T CD4+ and NK cells (below minimal control values). The number of T and NK cell subpopulations was not constant and this instability might have been the cause of immune response impairment observed in B-CLL patients. T lymphocytes and NK cells showed normal expression of an adhesion LFA-1 molecule.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree